
Cellebrite DI Ltd.
NASDAQ•CLBT
CEO: Mr. Yossi Carmil
セクター: Technology
業種: Software - Infrastructure
上場日: 2020-11-06
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.
連絡先情報
時価総額
$3.65B
PER (TTM)
49.4
41
配当利回り
--
52週高値
$25.47
52週安値
$13.10
52週レンジ
順位34Top 27.8%
4.7
F-Score
改良版 Piotroski 分析
6年ファンダメンタル
堅調 • 4.7 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2020-2025
財務ダッシュボード
Q3 2025 データ
売上高
$126.03M+17.94%
直近4四半期の推移
EPS
$0.08-108.37%
直近4四半期の推移
フリーCF
$29.95M-24.80%
直近4四半期の推移
2024 Annual 決算ハイライト
主なハイライト
Total Revenue Growth Total revenue reached $401.2M USD in 2024, showing a strong 23% increase compared to $325.1M USD in 2023.
Subscription Revenue Strength Subscription revenue increased 26% to $353.0M USD, driven by continuous adoption of Inseyets and Pathfinder solutions.
Adjusted EBITDA Improvement Adjusted EBITDA was $99.4M USD in 2024, significantly improving margin to 25% from 19% in prior year.
Net Loss Widened Net loss increased by $201.9M USD to $(283.0M) USD in 2024, reflecting significant financial expenses.
リスク要因
Government Sales Dependency Over 90% of 2024 revenue derived from government agencies, exposing results to budget cycles and appropriations uncertainty.
Technology Pace Risk Inability to keep pace with evolving OEM security and encryption may degrade Digital Investigative solution capabilities.
Geopolitical Instability Exposure Operations and supply chain face risks from ongoing Middle East conflicts and Israeli geopolitical instability impacting costs.
Key Personnel Retention Difficulty retaining and hiring permanent CEO and qualified personnel could disrupt strategic plans and operational results.
見通し
Inseyets Transition Focus Plan to accelerate Inseyets adoption among existing customers, migrating approximately 20% of installed base in 2024.
AI Technology Investment Increasing investment in AI, including new generative AI capabilities, to enhance flagship solutions and automate tasks.
U.S. Federal Expansion Strategy Established Cellebrite Federal Solutions and acquired CyTech to substantially broaden business with U.S. federal customers.
Customer Experience Elevation Launching 2025 initiative to elevate customer experience and drive continuous improvement in Gross Revenue Retention rates.
同業比較
売上高 (TTM)
COMP$6.64B
WEX$2.66B
STNE$2.37B
粗利益率 (最新四半期)
CLBT83.9%
QLYS83.4%
BOX79.5%
主要指標
銘柄コード | 時価総額 | PER (TTM) | ROE (TTM) | 負債比率 |
|---|---|---|---|---|
| COMP | $6.98B | -128.0 | -8.9% | 31.0% |
| DOCN | $5.86B | 23.3 | -153.0% | 92.3% |
| WEX | $5.69B | 18.8 | 29.4% | 33.7% |
長期トレンド
直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
4.9%
緩やかな成長
4四半期純利益CAGR
1.6%
収益性の緩やかな改善
キャッシュフロー安定性
100%
優れたキャッシュフローの実績
深度リサーチ
次回決算:2026年2月11日
EPS:$0.14
|売上高:$126.07M
財務レポート
財務データ
全年度
Form 20-F - FY 2024
会計期末: 2024年12月31日|提出日: 2025年3月18日|売上高: $401.20M+23.4%|EPS: $-1.35-214.0%予想を下回るForm 20-F/A - FY 2023
会計期末: 2023年12月31日|提出日: 2024年4月12日|売上高: $325.11M+20.1%|EPS: $-0.43-167.2%予想を下回るForm 20-F - FY 2023
会計期末: 2023年12月31日|提出日: 2024年3月21日|修正版データを参照Form 20-F - FY 2022
会計期末: 2022年12月31日|提出日: 2023年4月27日|売上高: $270.65M+9.9%|EPS: $0.64+28.0%予想を下回るForm 20-F/A - FY 2021
会計期末: 2021年12月31日|提出日: 2022年4月18日|売上高: $246.25M+26.3%|EPS: $0.50+1518.1%予想を上回るForm 20-F - FY 2021
会計期末: 2021年12月31日|提出日: 2022年3月29日|修正版データを参照